AI and Genetic Testing Revolutionize IVF, Offering Higher Success Rates and Healthier Pregnancies
Hyderabad (Telangana) [India], June 3 – Infertility is a growing concern for millions of couples around the world. Although in vitro fertilization (IVF) has offered hope, success rates have often been uncertain, with many couples needing multiple cycles to conceive. Today, breakthroughs in Artificial Intelligence (AI) and Preimplantation Genetic Testing (PGT) are changing that. These technologies are making fertility treatments more accurate, increasing IVF success rates, and helping ensure healthier pregnancies.
AI Brings Precision to IVF
Dr. S. Vyjayanthi, Director of MotherToBe Fertility Centre in Hyderabad, explains how AI is reshaping every stage of IVF, from embryo selection to sperm analysis.
Smarter Embryo Selection
Choosing the right embryo is one of the most important steps in IVF. Traditionally, embryologists select embryos by visually inspecting them under a microscope—a process that can be subjective. AI changes this by:
−Analyzing thousands of embryo images
−Detecting subtle features invisible to the human eye
−Predicting the likelihood of successful implantation
−Using machine learning, AI systems assign scores to embryos based on shape, development, and genetic health. This helps doctors select the embryo with the highest chance of success.
Better Ovarian Stimulation Monitoring
Before eggs are collected, patients go through ovarian stimulation. Correct medication dosage is critical to avoid complications like Ovarian Hyperstimulation Syndrome (OHSS). AI helps by:
−Tracking hormone levels and follicle growth in real time
−Adjusting medication based on patient data
−Improving safety and egg quality
More Accurate Sperm Analysis
Male infertility accounts for nearly half of all infertility cases. Traditional sperm tests are manual and may vary in accuracy. AI-powered analysis offers:
−Detailed assessment of sperm motility and shape
−Better selection of sperm for IVF or ICSI
−Insights into sperm DNA quality
This leads to better fertilization rates and embryo health.
Genetic Testing Adds a New Layer of Assurance
Preimplantation Genetic Testing (PGT) is another tool improving IVF outcomes. It allows doctors to identify genetic problems in embryos before implantation.
Three Main Types of PGT:
−PGT-A (Aneuploidy Screening): Detects abnormal chromosome numbers to prevent conditions like Down syndrome and reduce miscarriage risk.
−PGT-M (Monogenic Disorders): Screens for inherited diseases such as cystic fibrosis or sickle cell anemia.
−PGT-SR (Structural Rearrangements): Identifies chromosomal shifts that could cause failed pregnancies.
By testing a few cells from each embryo before transfer, PGT ensures only healthy embryos are used, which increases the chance of a healthy pregnancy.
A Powerful Combination: AI + PGT
When used together, AI and PGT provide a powerful advantage in fertility treatments. Their combined benefits include:
−Better embryo selection
−Lower risk of IVF failure and miscarriage
−Safer single embryo transfers, reducing multiple pregnancies
−More personalized care for each patient
“AI and genetic testing have transformed IVF into a more patient-friendly and precise treatment,” says Dr. Vyjayanthi. “At MotherToBe, we use both to maximize success and help more couples start families.”
Who Benefits Most?
AI and PGT are especially helpful for:
−Women over 35 with low ovarian reserve
−Couples with repeated IVF failures
−Women with frequent miscarriages
−Couples with known genetic risks (e.g., BRCA, Thalassemia)
−Men with low sperm quality
MotherToBe Fertility Centre uses AI-assisted tools and genetic testing to give these patients the best chance at successful parenthood.
Conclusion
AI and genetic testing are reshaping IVF. They’re offering renewed hope to those struggling with infertility—making treatments safer, more effective, and more personalized.
Couples considering IVF are encouraged to explore advanced care options. For consultations, visit MotherToBe Fertility Centre, a leader in AI-powered fertility treatments and PGT-based embryo selection, located in Hyderabad.
Related topics:
